Abstract
The synonym is M. chamomilla L., and M. recutita is commonly known as German chamomile and true chamomile (Kreitmair 1951). The plant is native to Afghanistan, Europe and Iran (Formentini and Rocchi 1961). The dried flower heads are utilized in ethnomedicine for preparation of tea with antispasmodic (spasmolytic) and sedative properties (Viola et al. 1995).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Amsterdam JD, Li Y, Soeller I, Rockwell K, Mao JJ, Shults J. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. J Clin Psychopharmacol. 2009;29:378–82.
Amsterdam JD, Shults J, Soeller I, Mao JJ, Rockwell K, Newberg AB. Chamomile (Matricaria recutita) may provide antidepressant activity in anxious, depressed humans: an exploratory study. Altern Ther Health Med. 2012;18:44–9.
Can OD, Demir Özkay U, Kıyan HT, Demirci B. Psychopharmacological profile of Chamomile (Matricaria recutita L.) essential oil in mice. Phytomedicine. 2012;19:306–10.
Carnat A, Carnat AP, Fraisse D, Ricoux L, Lamaison JL. The aromatic and polyphenolic composition of Roman chamomile tea. Fitoterapia. 2004;75:32–8.
Chandrashekhar VM, Ranpariya VL, Ganapaty S, Parashar A, Muchandi AA. Neuroprotective activity of Matricaria recutita Linn against global model of ischemia in rats. J Ethnopharmacol. 2010;127:645–51.
Formentini L, Rocchi B. Contribution to the pharmacopoeia. Proposed monograph on Matricaria chamomilla. Boll Chim Farm. 1961;100:37–9.
Grigson G. The Englishman’s Flora. Oxford: Helicon Publishing Ltd; 1996.
Keefe JR, Mao JJ, Soeller I, Li QS, Amsterdam JD. Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder. Phytomedicine. 2016;23:1699–705.
Kreitmair H. Matricaria chamomilla L., the true chamomile. Pharmazie. 1951;6:65–6.
Luppold E. Matricaria chamomilla-an old and new medicinal plant. Pharm Unserer Zeit. 1984;13:65–70.
Mabey R. Flora Britannica. London: Sinclair-Stevenson; 1996.
Mao JJ, Xie SX, Keefe JR, Soeller I, Li QS, Amsterdam JD. Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: a randomized clinical trial. Phytomedicine. 2016;23:1735–42.
Ranpariya VL, Parmar SK, Sheth NR, Chandrashekhar VM. Neuroprotective activity of Matricaria recutita against fluoride-induced stress in rats. Pharm Biol. 2011;49:696–701.
Viola H, Wasowski C, Levi de Stein M, Wolfman C, Silveira R, Dajas F, Medina JH, Paladini AC. Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects. Planta Med. 1995;61:213–6.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Saroya, A.S., Singh, J. (2018). Neuropharmacology of Chamomiles. In: Pharmacotherapeutic Potential of Natural Products in Neurological Disorders. Springer, Singapore. https://doi.org/10.1007/978-981-13-0289-3_9
Download citation
DOI: https://doi.org/10.1007/978-981-13-0289-3_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-0288-6
Online ISBN: 978-981-13-0289-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)